Evidence map›Paper›PMID 34660244›Full record

ArticleIndian journal of endocrinology and metabolism

Low-Dose, Low-Specific Activity

Rohit Barnabas, Sanjeet Kumar Jaiswal, Saba Samad Memon, Vijaya Sarathi, Gaurav Malhotra, Priyanka Verma, Virendra A Patil, Anurag R Lila, Nalini S Shah, Tushar R Bandgar

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of endocrinology and metabolism. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rohit BarnabasDepartment of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Sanjeet Kumar JaiswalDepartment of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Saba Samad MemonDepartment of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Vijaya SarathiDepartment of Endocrinology, Vydehi Institute of Medical Sciences and Research Center, Bengaluru, Karnataka, India.
Gaurav MalhotraDepartment of Nuclear Medicine, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Priyanka VermaDepartment of Nuclear Medicine, Bhabha Atomic Research Centre, Mumbai, Maharashtra, India.
Virendra A PatilDepartment of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Anurag R LilaDepartment of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Nalini S ShahDepartment of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Tushar R BandgarDepartment of Endocrinology, Seth G.S Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Bhabha Atomic Research Centre · INInstitute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRadionuclide therapy is a promising treatment modality in metastatic pheochromocytoma/paraganglioma (PPGL). There is scarce data on

methodsClinical, hormonal, and radiological response parameters and side effects of LSA

resultsSeventeen (PCC: 11, sympathetic PGL: 06) patients (15 with disease progression) received low-dose LSA

conclusionsOur study reaffirms the modest efficacy and safety of low-dose, LSA

Indexed as

131I-MIBGlow-specific activityparagangliomapheochromocytoma

Identifiers

PMID34660244
PMCPMC8477742
OpenAlexW3196311954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.